Abstract
Men presenting with clinically confined prostate cancer have a variety of established treatment options, among them brachytherapy is gaining increased acceptance, even in the absence of randomized comparative data between brachytherapy, surgery and external radiotherapy. This review summarizes the results of low dose rate transrectal-guided transperineal permanent seed implantation brachytherapy. We present the evolution of the different treatment planning techniques and a comprehensive review of published mature data on 10-year or longer of biochemical and survival outcome for brachytherapy alone, and brachytherapy combined with supplemental external beam radiation therapy with emphasis on its impact on quality of life.
| Original language | English |
|---|---|
| Pages (from-to) | 203-211 |
| Number of pages | 9 |
| Journal | Minerva Urologica e Nefrologica |
| Volume | 62 |
| Issue number | 2 |
| State | Published - 1 Jun 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Brachytherapy
- Penile prosthesis
- Prostatic neoplasms
ASJC Scopus subject areas
- Nephrology
- Urology
Fingerprint
Dive into the research topics of 'The role of brachytherapy in the 21st century for prostate cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver